Ischemic heart disease decisions — 2025

The Board denied the Veteran's claim for service connection for a heart condition, finding no evidence that it was incurred in or caused by military service.

The Board remands the claims for service connection for a heart disorder and diabetes mellitus, to include as due to ionizing radiation exposure, as there has not been substantial compliance with previous remand directives.

The Board denied an earlier effective date for the grant of service connection for arteriosclerotic heart disease, finding that January 18, 2023, is the earliest possible effective date.

The Board remands the claims for service connection for chronic obstructive pulmonary disease, coronary artery disease, and testicular cancer to obtain additional evidence.

The Board granted service connection for diabetes mellitus type II, ischemic heart disease, and hypertension on a presumptive basis due to herbicide exposure.

The Board remands the claims for an increased rating for hypertensive heart disease with syncopal episodes, TDIU, service connection for a bowel and/or bladder disability, and service connection for headaches to afford the Veteran another opportunity for VA examinations.

The Board granted a 30 percent disability rating for the Veteran's heart condition effective May 1, 2024.

The Board denied service connection for fatty liver, atrial fibrillation, heart disorder (ischemic heart disease), pancreatitis, and gall bladder removal as they were not shown to be related to the Veteran's active military service or in-service toxic exposure risk activities.

The Board granted an earlier effective date of December 26, 2012, for the award of a 60 percent rating for service-connected heart disease.

The Board denied service connection for various conditions, including bilateral knee, hearing loss, tinnitus, skin rash, and sleep apnea. The Veteran was granted a 20 percent rating for diabetic neuropathy of the femoral nerve in both lower extremities.

The Board grants an earlier effective date of November 11, 2014, for service connection for a coronary artery bypass graft.

The Board granted an effective date of August 10, 2022, but no earlier, for the grant of service connection for a heart disability and denied earlier effective dates for other conditions.

The Board granted service connection for hypertension and arteriosclerotic heart disease based on presumed exposure to herbicide agents during service, pursuant to the PACT Act.

The Board denied service connection for heart disease and hyperlipidemia, finding no evidence of a current disability or a link to the Veteran's military service.

The Board denied an increased rating for coronary artery disease and a compensable rating for hypertension, while remanding the claim for hypothyroidism.

The Board denied the veteran's claims for earlier effective dates for service connection for various conditions, including coronary artery disease and Parkinson's disease, as there was no evidence of direct or presumed exposure to herbicide agents prior to the enactment of the PACT Act on August 10, 2022.

The Board denied service connection for autoimmune arthritis and denied initial ratings in excess of 10 percent, 60 percent, and 20 percent for atrial fibrillation, coronary artery disease, and diabetes mellitus, respectively. The Board also denied an initial compensable rating for a residual scar associated with CAD and denied initial ratings in excess of 10 percent for bilateral lower extremity femoral and sciatic nerve neuropathies.

The Board denied service connection for a heart disability, to include residuals of myocardial infarction and coronary artery disease, and denied a compensable rating for pseudofolliculitis barbae. The Board also denied a rating in excess of 10 percent prior to June 5, 2023, and a rating in excess of 30 percent from June 5, 2023, for scars, neck and left cheek, associated with pseudofolliculitis barbae. However, the Board granted service connection for a left second digit scar with pain.

The Board granted service connection for coronary artery disease, atherosclerotic cardiovascular disease, valvular heart disease to include aortic atherosclerosis as secondary to posttraumatic stress disorder with major depressive disorder and bruxism based on the most probative evidence supporting a relationship between the Veteran's PTSD and his heart condition.

The Board denied the Veteran's appeal for an earlier effective date for service connection of coronary artery disease with angina, as there was no evidence of a formal claim or new and relevant evidence received prior to April 28, 2023.